Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

NCT02895100 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
98
Enrollment
INDUSTRY
Sponsor class

Stopped Data Monitoring Committee discontinued the trial due to futility-based outcome

Conditions

Interventions

Sponsor

Protagonist Therapeutics, Inc.